Switzerland: SK Capital to sell Noramco, Extractas Bioscience, and Purisys to Siegfried
Life sciences PE Firm, SK Capital, is to sell the drug substance business of the Noramco Group and Extractas Bioscience to Six-listed Siegfried Holding,...
Belgium: Gimv discontinues activities for new Life Sciences investments
Belgium-based private equity firm, Gimv, will not be making any further new investments in its Life Sciences platform.
In line with its strategic priorities and growth ambitions,...
UK: Spire Healthcare confirms discussions on a potential sale with Bridgepoint and Triton
Spire Healthcare, a UK provider of private healthcare, running 38 private hospitals and over 50 clinics, consulting rooms and medical centres, has confirmed it...
UK: CMA seeks views on Welltower’s care home acquisitions
The UK Competition and Markets Authority (CMA) is seeking views on four completed acquisitions by Welltower of care homes managed by Barchester, HC-One, Aria...
US: Bridgefield completes acquisition of Philips’ Emergency Care business and formally launches Emergency Care...
US-based Bridgefield Capital has closed the acquisition, announced in 2025, of the Philips Emergency Care business from Philips and launched Emergency Care Holdings (ECH),...
Germany: Rudischhauser becomes latest addition to Gilde’s Surgical Instrument Contract Manufacturing Group
Thematic investor Gilde Healthcare has expanded its Surgical Instrument Contract Manufacturing Group (the Group) with the acquisition of Germany-based medtech Rudischhauser Surgical Instruments Manufacturing,...
UK: Pharmacy2U acquires Care Quality Pharmacy
Pharmacy2U, a UK-based online pharmacy and a portfolio company of G Square, has taken its first step into the care home sector with the...
Singapore: Specac acquires Amax Precision
UK-based Specac, an Ampersand Capital Partners portfolio company that designs and manufactures spectroscopy accessories and sample prep solutions, has acquired Amax Precision, a Singapore-headquartered...
France: bioMérieux completes its offering for cell and gene therapies with acquisition of Accellix
France-based bioMérieux, a family-owned global leader in the field of in vitro diagnostics, has acquired the entire share capital of Accellix, increasing its stake from roughly...
Switzerland: Oviva raises €200m in one of the biggest Series D rounds in digital...
Switzerland-based Oviva, one of Europe’s leading providers of digital, reimbursed care for weight-related and chronic conditions, has closed a €200m (US$234m) Series D financing...
Advertisement
